Velocity Clinical Research, Lincoln is a clinical research site located in Lincoln, Nebraska, United States 68510.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
Velocity Clinical Research, Lincoln has participated in 5 clinical trials with 3 currently active.
Therapeutic areas: Respiratory Syncytial Virus, SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2.
Sponsors: ModernaTX, Inc., BioNTech SE, Sparrow Pharmaceuticals.
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Velocity Clinical Research, Lincoln has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Velocity Clinical Research, Lincoln has 5 clinical trials on record, with 3 currently active. Their work covers Respiratory Syncytial Virus, SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2.
Yes — Velocity Clinical Research, Lincoln holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.